肝脏硬度严重程度与2型糖尿病患者心血管风险增加相关
本研究旨在明确磁共振弹性成像(MRE)评估的肝纤维化分期是否与Framingham风险评分(FRS)和冠状动脉钙化(CAC)判定的心血管疾病(CVD)风险相关。研究聚焦于2型糖尿病(DM2)合并非酒精性脂肪性肝病(NAFLD)患者,原文摘要未报告具体样本量、效应值及统计学结论。
要点
- MRE是NAFLD中无创评估肝纤维化最准确的方法。
- NAFLD患者CVD风险与2型糖尿病密切相关,准确评估CVD风险对改善临床结局至关重要。
- MRE评估的纤维化严重程度与CVD风险程度之间的关联此前未知。
核心结论
- 原文摘要未报告研究结论。
研究设计与样本
- 研究目的为确定MRE评估的肝纤维化分期是否与FRS和CAC判定的CVD风险相关,研究对象为NAFLD合并2型糖尿病患者,原文摘要未报告样本量与研究设计类型。
主要发现
- 原文摘要未报告具体研究结果。
关键数值与推荐
- 原文摘要未报告关键数值或推荐条款。
临床怎么用
- 原文摘要未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cardiovascular disease (CVD) is the leading cause of death among patients with nonalcoholic fatty liver disease (NAFLD) and is strongly associated with type 2 diabetes mellitus (DM2).1 Accurately assessing CVD risk in NAFLD patients is critical to improving clinical outcomes.1 Use of liver stiffness measurements to noninvasively assess for liver fibrosis is broadening, and magnetic resonance elastography (MRE) is the most accurate modality in NAFLD.2 However, the association between fibrosis severity on MRE and the degree of CVD risk is unknown. The aim of this study was to determine whether MRE-assessed liver fibrosis stage is associated with CVD risk determined by Framingham risk score (FRS) and coronary artery calcium (CAC).
引用
- Mangla N, Ajmera VH, Caussy C, et al. Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes. Clin Gastroenterol Hepatol. 2019. PMID: 31100460. doi:10.1016/j.cgh.2019.05.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。